How to improve adherence to antipsychotic treatment: Outcomes of the IMproving PAtient outComes in psychiaTry (IMPACT) Berlin 2009 meeting workshop

International Journal of Psychiatry in Clinical Practice

Volumn 13, Issue 4, 2009, Pages 245-252

  Kasper, Siegfried ^a   Saya, Laurence ^b   Tekin, Beril ^c   Loze, Jean Yves ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Altius Pharma CS ^*  (France)

^c BRISTOL MYERS SQUIBB   (United States)

^d Otsuka Pharmaceutical   (France)

Author keywords

Adherence; Antipsychotic; Medical education; Mental illness; Partnership; Workshop

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL PRACTICE; COGNITIVE THERAPY; DOCTOR PATIENT RELATION; EXPECTATION; INTERPERSONAL COMMUNICATION; INTERVENTION STUDY; MENTAL DISEASE; MOTIVATION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHIATRIST;

EID: 70350746378     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651500903359861     Document Type: Article

References (23)

1. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002;/63:/ 384-90.
2. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 2002;/159:/1927-9.
3. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;/63:/892-909.
4. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995;/21:/419-29.
5. Morken G, Widen JH, Grawe RW. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia. BMC Psychiatry 2008;/30;8:/32.
6. Robinson D,Woerner MG,Ma J, Alvir J, Bilder R, Goldman R, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999;/56:/241-7. (Pubitemid 29125132)
7. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med 2005;/353:/487-97.
8. Fleischhacker WW, Oehl MA, Hummer M. Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 2003;/64(Suppl 16):/10-3.
9. Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Mö ller HJ; WFSBP Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia. World J Biol Psychiatry 2006;7:5-40. (Pubitemid 43878525)
10. Nelson AA Jr, Gold BH, Hutchinson RA, Benezra E. Drug default among schizophrenic patients. Am J Hosp Pharm 1975;/32:/1237-42.
11. NICE and NCCPC. Medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence. January 2009. Available from www.nice.org.uk/CG76 (accessed 11 May 2009).
12. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD000011. DOI: 10.1002/14651858.CD000011. pub3.
13. Fleischhaker WW, Hofer A, Hummer M. Managing schizophrenia: the compliance challenge. 2nd ed. Current Medicines Group. London: Springer Science-Business Media; 2007.
14. Buckley PF, Wirshing DA, Bhushan P, Pierre JM, Resnick SA, Wirshing WC. Lack of insight in schizophrenia: impact on treatment adherence. CNS Drugs 2007;/21:/129-41.
15. Olfson S, Marcus SC, Wilk J, West JC. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia. Psychiatr Serv 2006;/57:/205-11.
16. Berk M, Berk L, Castle D. A collaborative approach to the treatment alliance in bipolar disorder. Bipolar Disord 2004;/ 6:/504-18.
17. Rittmannsberger H, Pachinger T, Keppelmuller P, Wancata J. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr Serv 2004;/55:/ 174-9.
18. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(Suppl 4):1-46.
19. McCabe R, Priebe S. The therapeutic relationship in the treatment of severe mental illness: a review of methods and findings. Int J Soc Psychiatry 2004;/50:/115-28.
20. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 2000;/40:/ 173-85.
21. Gaudiano BA, Weinstock LM, Miller IW. Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behav Modif 2008;/32(3):/ 267-301.
22. Patterson TL, Leeuwenkamp OR. Adjunctive psychosocial therapies for the treatment of schizophrenia. Schizophr Res 2008;/100:/108-19.
23. Julius RJ, Novitsky MA, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract 2009;/15:/34-44.